Deterioration of pulmonary hypertension and pleural effusion with bosutinib following dasatinib lung toxicity-Reference-Cited by-同舟云学术

Deterioration of pulmonary hypertension and pleural effusion with bosutinib following dasatinib lung toxicity

Published:2016-10-06 Issue:5 Volume:48 Page:1517-1519
ISSN:0903-1936
Container-title:European Respiratory Journal
language:en
Short-container-title:Eur Respir J

Author:

Riou Marianne,Seferian Andrei,Savale Laurent,Chaumais Marie-Camille,Guignabert Christophe^ORCID,Canuet Matthieu,Magro Pascal,Rea Delphine,Sitbon Olivier,Jaïs Xavier,Humbert Marc,Montani David

Publisher

European Respiratory Society (ERS)

Subject

Pulmonary and Respiratory Medicine

Reference15 articles.

1. Chronic myelogenous leukemia, version 1.2015;O'Brien;J Natl Compr Canc Netw,2014

2. Dasatinib-Induced Pleural Effusions: A Lymphatic Network Disorder?

3. Pulmonary Arterial Hypertension in Patients Treated by Dasatinib

4. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension

5. Incidence, risk factors and management of pleural effusions during dasatinib treatment in unselected elderly patients with chronic myelogenous leukaemia

Cited by 47 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pathology and pathobiology of pulmonary hypertension: current insights and future directions;European Respiratory Journal;2024-08-29

2. Critical review of clinical data and expert-based recommendations for the use of bosutinib in the treatment of chronic myeloid leukemia;Frontiers in Oncology;2024-08-26

3. Practical considerations in the management of patients treated with bosutinib for chronic myeloid leukemia;Annals of Hematology;2024-07-18

4. Incidence of pleural effusion with dasatinib and the effect of switching therapy to a different TKI in patients with chronic phase CML;Annals of Hematology;2024-04-18

5. Cancer Therapy-Associated Pulmonary Hypertension and Right Ventricular Dysfunction: Etiologies and Prognostic Implications;Reviews in Cardiovascular Medicine;2024-03-05